Tenax Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-14.8M | $-14.8M | — | $1.1M |
| FY2025 | $-35.8M | $-35.8M | — | $19.2M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-14.8M | $-14.8M | — | $1.1M |
| FY2025 | $-35.8M | $-35.8M | — | $19.2M |